208 related articles for article (PubMed ID: 33270844)
21. Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles.
Shi C; Huang K; Soto J; Sankaran R; Kalia V; Onwumere O; Young M; Einbond L; Redenti S
Biomed Pharmacother; 2023 May; 161():114554. PubMed ID: 36940616
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
Liu S; Yan G; Zhang J; Yu L
Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
[TBL] [Abstract][Full Text] [Related]
23. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
Shang Y
Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
[TBL] [Abstract][Full Text] [Related]
24. Genomic differences between retinoma and retinoblastoma.
Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
[TBL] [Abstract][Full Text] [Related]
25. [From gene to disease; retinoblastoma and the RB1 gene].
Scheffer H; Imhof SM; Moll AC
Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1245-7. PubMed ID: 11455690
[TBL] [Abstract][Full Text] [Related]
26. High-Level
Roohollahi K; de Jong Y; van Mil SE; Fabius AWM; Moll AC; Dorsman JC
Ophthalmol Sci; 2022 Sep; 2(3):100188. PubMed ID: 36245757
[TBL] [Abstract][Full Text] [Related]
27. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.
Suenaga Y; Nakatani K; Nakagawara A
Jpn J Clin Oncol; 2020 Aug; 50(8):839-846. PubMed ID: 32577751
[TBL] [Abstract][Full Text] [Related]
28. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
29. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
[TBL] [Abstract][Full Text] [Related]
30. Which retinoblastoma patients should be screened for RB1 mutations?
Cowell JK; Gallie BL
Eur J Cancer; 1998 Nov; 34(12):1825-6. PubMed ID: 10023301
[No Abstract] [Full Text] [Related]
31. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
[TBL] [Abstract][Full Text] [Related]
32. LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340.
Yu J; Ou Z; Lei Y; Chen L; Su Q; Zhang K
Hum Cell; 2020 Jan; 33(1):148-158. PubMed ID: 31776854
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
34. MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN.
Li H; Fan D; Wang W; Zhang X; Song L; Huang Y
Biochem Biophys Res Commun; 2021 Oct; 574():20-26. PubMed ID: 34425282
[TBL] [Abstract][Full Text] [Related]
35. TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.
Suenaga Y; Yamamoto M; Sakuma T; Sasada M; Fukai F; Ohira M; Yamaguchi Y; Yamamoto T; Ando K; Ozaki T; Nakagawara A
Biochem Biophys Res Commun; 2019 Oct; 518(2):311-318. PubMed ID: 31427086
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of the RB1 gene in Indian patients with retinoblastoma.
Ata-ur-Rasheed M; Vemuganti Gk; Honavar Sg; Ahmed N; Hasnain Se; Kannabiran C
Ophthalmic Genet; 2002 Jun; 23(2):121-8. PubMed ID: 12187430
[TBL] [Abstract][Full Text] [Related]
37. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.
Wu N; Jia D; Bates B; Basom R; Eberhart CG; MacPherson D
J Clin Invest; 2017 Mar; 127(3):888-898. PubMed ID: 28165337
[TBL] [Abstract][Full Text] [Related]
38. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression.
Liu J; Ottaviani D; Sefta M; Desbrousses C; Chapeaublanc E; Aschero R; Sirab N; Lubieniecki F; Lamas G; Tonon L; Dehainault C; Hua C; Fréneaux P; Reichman S; Karboul N; Biton A; Mirabal-Ortega L; Larcher M; Brulard C; Arrufat S; Nicolas A; Elarouci N; Popova T; Némati F; Decaudin D; Gentien D; Baulande S; Mariani O; Dufour F; Guibert S; Vallot C; Rouic LL; Matet A; Desjardins L; Pascual-Pasto G; Suñol M; Catala-Mora J; Llano GC; Couturier J; Barillot E; Schaiquevich P; Gauthier-Villars M; Stoppa-Lyonnet D; Golmard L; Houdayer C; Brisse H; Bernard-Pierrot I; Letouzé E; Viari A; Saule S; Sastre-Garau X; Doz F; Carcaboso AM; Cassoux N; Pouponnot C; Goureau O; Chantada G; de Reyniès A; Aerts I; Radvanyi F
Nat Commun; 2021 Sep; 12(1):5578. PubMed ID: 34552068
[TBL] [Abstract][Full Text] [Related]
39. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
Qi DL; Cobrinik D
Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA
Dong Y; Wan G; Yan P; Qian C; Li F; Peng G
Aging (Albany NY); 2020 May; 12(9):7729-7746. PubMed ID: 32369777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
